fbpx

Bridging Gap

Bridging Gap

Integrated Marketing Communication Agency.

We craft beautifully useful marketing and digital products that grow businesses.

T (917) 720 3126
Email: gaurav.sodhi@bridginggap.in

Bridging gap (B.Gap Pvt. Ltd.)
244 Fifth Avenue, Manhattan New York, NY, US 10001

Get in touch: +91-983-383-0474
  • MY CART
    No products in cart.
  • About us
  • Voice Your Business
    • India
    • USA
  • Services
    • Web & Mobile Development
    • SEO Services
    • Graphic Design
    • Marketing
      • Experiential Marketing (Events)
      • Email Marketing
      • Social Media Marketing
      • Hotel Marketing
    • Social Media
    • Brand Building
  • Portfolio
    • Strategic Creations
  • Beyond the Bridge
  • Contact us
Enquiry
0
Friday, 28 January 2022 / Published in Uncategorized

Moderna launches clinical trial for HIV vaccine that uses mRNA technology – ABC News

The first participants were given doses of the vaccine Thursday.
On Location: January 27, 2022
Moderna announced Thursday that it’s launched early-stage clinical trials of an HIV mRNA vaccine.
The biotechnology company has teamed up with the nonprofit ​​International AIDS Vaccine Initiative to develop the shot, which uses the same technology as Moderna’s successful COVID-19 vaccine.
The first participants in the Phase I trial were given doses at George Washington University School of Medicine and Health Sciences in Washington, D.C., according to a company statement.
“We are tremendously excited to be advancing this new direction in HIV vaccine design with Moderna’s mRNA platform,” Dr. Mark Feinberg, president and CEO of IAVI, said in a statement. “The search for an HIV vaccine has been long and challenging, and having new tools in terms of immunogens and platforms could be the key to making rapid progress toward an urgently needed, effective HIV vaccine.”
Nearly 38 million people worldwide — including about 1.3 million in the U.S — are living with HIV, or human immunodeficiency virus, which can lead to the potentially fatal disease AIDS.
Being diagnosed with HIV was once considered a death sentence. During the height of the U.S. AIDS epidemic in the mid-1990s, more than 50,000 deaths occurred every year, according to the Centers for Disease Control and Prevention.
Today, HIV is much more manageable with medications that can reduce viral loads to undetectable so the virus can’t be transmitted, as well as pills that can be taken to prevent infecting those who are HIV-negative.
But despite decades of research, no vaccine has ever been developed. Several candidates have entered clinical trials but failed in later stages.
The new vaccine uses mRNA, or messenger RNA, which teaches the body’s cells how to make proteins that trigger immune responses.
Researchers have developed not only a primary vaccine but also a booster to deliver HIV immunogens — molecules that elicit an immune response — via mRNA.
The hope is this process can induce specific white blood cells, called B cells, which can then turn into what are known as broadly neutralizing antibodies that can neutralize the virus.
According to the statement, Phase I of the trial will enroll 56 healthy, HIV-negative adult participants at GWU and three additional sites: Hope Clinic of Emory Vaccine Center in Atlanta; Fred Hutchinson Cancer Research Center in Seattle; and the University of Texas-Health Science Center at San Antonio.
Of the volunteers, 48 will receive one or two doses of the mRNA vaccine, and 32 also will receive the booster. The remaining eight will receive just the booster.
Researchers will then monitor for safety and efficacy of the new vaccine for up to six months after participants receive their final dose.
Moderna did not immediately respond to ABC News’ request for comment.
ABC News’ Sony Salzman contributed to this report.
24/7 coverage of breaking news and live events

source

  • Tweet

What you can read next

New Internet Marketing Company Launches Seeking to Demystify SEO for Businesses – PRNewswire
Help teachers do their jobs – Lewiston Sun Journal – Lewiston Sun Journal
14.5 million Americans sign up for coverage during open enrollment – Healthcare Finance News

Recent Posts

  • SEO service in Bandra

    Beyond Keywords: How Search Intent is Shaping SEO Strategies in 2025

    In the dynamic realm of digital marketing, unde...
  • Best Hotel Marketing Agency

    OTA vs Direct bookings- How Hotels can achieve Maximum Revenue ?

    Best Hotel Marketing Agency...
  • Google Vs SEO

    Google Ads vs. SEO – Which Is Better? Get Expert Strategy from Bridging Gap, Mumbai

    In the fast-paced world of digital marketing, b...
  • best digital marketing agency in Delhi

    Branding Beyond the Logo: The Emotional Triggers That Make Customers Buy

    Introduction to Branding Branding is much more ...
  • Bridging Gap: 40% Revenue Increase for a Resort Through Smart OTA Strategies

    The hospitality industry is fiercely competitiv...

Archives

  • February 2025
  • January 2025
  • December 2024
  • May 2024
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • June 2017

Categories

  • Branding
  • Marketing
  • News
  • SEO
  • Social Media
  • Uncategorized
  • Web Design

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
Company
  • About us
  • Voice Your Business
  • Services
  • Portfolio
  • Beyond the Bridge
  • Contact us
Social
  • Instagram
  • Facebook
  • Twitter
Support
  • FAQ
  • Terms
  • Privacy

Bridging Gap

Call USA :+1-347-587-8585

Call IND: +91-983-383-0474

info@bridginggap.in

© 2025 All rights Reserved @Bridging Gap.

TOP